Patent litigation is a complex and strategic endeavor, requiring thorough preparation and careful consideration. Before proceeding with a lawsuit, patent owners should evaluate several critical ...

Moderna will pay up to $2.25B to settle a patent lawsuit over lipid nanoparticle technology used in its COVID-19 vaccine.

An expert Q&A on the US Patent and Trademark Office’s (USPTO’s) 2025 guidance memoranda addressing the Patent Trial and Appeal Board’s (PTAB’s) approach to discretionary denials of inter partes review ...

A Perfect Storm for Increased Patent Litigation in 2026 2026 is expected to be a record year for U.S. patent litigation, driven by pro-patent policies, advanced AI tools, and increased litigation ...

“The CAFC said the district court found ‘the ’091 patent was ‘demonstrably weak on its face, despite the initial presumptions created when the patent was issued by the PTO.’” The U.S. Court of Appeals ...

“The Federal Circuit… ruled that such a due process violation could only be asserted by whoever claimed to be the true [patent owner].” Today, the U.S. Court of Appeals for the Federal Circuit (CAFC) ...

Once the active ingredient is defined, an Applicant must select which patent, or patents, to put forward for extension. The statute permits only one PTE per regulatory review period, so the choice is ...